Higher prevalence of depressive and anxiety symptoms in early arthritis patients in comparison to the normal populatio

• Conditions: M13.0; Polyarthritis, unspecified; Reaction to severe stress, and adjustment disorders; F43

• Registration Number: DRKS00011303
• Lead Sponsor: Charité-Universitätsmedizin BerlinKlinik m.S. Rheumatologie und Klinische Immunologie

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2015-04-01
• Study Start: 2017-02-03
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 176

Inclusion Criteria

age = 18 years; at least one swollen joint; symptoms duration between 4 weeks and 12 months; fully documented HADS questionnaire

Exclusion Criteria

criteria for early arthritis are not applicable; suspected of trauma, surgery, infections in the area of symptomatic joints

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Prevalence rates of depression and anxiety in early arthritis patients at first visiting by the rheumatologist measured by the Hospital Anxiety and Depression Scale (HADS)

Secondary Outcome Measures

Name	Time	Method
Comparison of factors influencing both rheumatic disease and depression and anxiety disorders (e.g., indicators of disease activity, age, gender)